Ambiq Micro (AMBQ) Registration Filing summary

Company overview and business model

• Designs ultra-low power semiconductor solutions for edge AI, leveraging proprietary SPOT® technology to reduce power consumption by 2–5x compared to conventional chips.

• Products include SoCs and software for personal devices, medical/healthcare, industrial edge, and smart home/building markets.

• Operates a fabless model, outsourcing manufacturing to TSMC and other partners.

• Over 290 million devices shipped; 26 million units shipped in 2025, with 80% running AI algorithms.

Financial performance and metrics

• Net sales for 2024: $76.1M (up 16.1% from 2023); net loss for 2024: $39.7M; accumulated deficit as of September 30, 2025: $346.0M.

• Gross margin improved to 31.9% in 2024 (from 29.7% in 2023); gross margin for nine months ended September 30, 2025: 44.9%.

• Net sales outside Mainland China grew 70% in 2024 and 61.2% for the first nine months of 2025; Mainland China sales decreased due to strategic shift.

• Cash and cash equivalents as of September 30, 2025: $146.5M.

• Non-GAAP net loss for 2024: $28.6M; non-GAAP gross profit for 2024: $23.9M.

Use of proceeds and capital allocation

• Estimated net proceeds of $65.2M (or $75.4M if underwriters' option exercised) based on $33.02/share.

• Proceeds intended for general corporate purposes: working capital, sales/marketing, product development, admin, and capex; may also be used for acquisitions, though none are planned.

• No plans to pay dividends; funds to be retained for growth and operations.